Design, synthesis, docking studies and biological evaluation of novel dihydro-1,3,5-triazines as human DHFR inhibitors.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European journal of medicinal chemistry

• Publication date

  2017-01-05

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejmech.2016.11.010PMID 27886545
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pemetrexed for advanced stage nonsquamous non-small cell lung cancer: latest evidence about its extended use and outcomes

  2016cited by this paper
• Methotrexate and 5-aminoimidazole-4-carboxamide riboside exert synergistic anticancer action against human breast cancer and hepatocellular carcinoma

  2013cited by this paper
• Design and synthesis of small molecular dual inhibitor of falcipain-2 and dihydrofolate reductase as antimalarial agent.

  2012cited by this paper
• Establishment of an orthotopic lung cancer model in nude mice and its evaluation by spiral CT.

  2012cited by this paper
• Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance.

  2012cited by this paper
• Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target

  2012cited by this paper
• Preferential selection of isomer binding from chiral mixtures: alternate binding modes observed for the E and Z isomers of a series of 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines as ternary complexes with NADPH and human dihydrofolate reductase.

  2010cited by this paper
• Antifolate and antiproliferative activity of 6,8,10-triazaspiro[4.5]deca-6,8-dienes and 1,3,5-triazaspiro[5.5]undeca-1,3-dienes.

  2010cited by this paper
• Structural analysis of Pneumocystis carinii and human DHFR complexes with NADPH and a series of five potent 6-[5'-(ω-carboxyalkoxy)benzyl]pyrido[2,3-d]pyrimidine derivatives.

  2010cited by this paper
• Multiple Conformers in Active Site of Human Dihydrofolate Reductase F31R/Q35E Double Mutant Suggest Structural Basis for Methotrexate Resistance*

  2009cited by this paper
• Antiproliferative Activity Against MCF‐7 Breast Cancer Cells by Diamino‐Triazaspirodiene Antifolates

  2009cited by this paper
• Fully Automated Molecular Mechanics Based Induced Fit Protein-Ligand Docking Method

  2008cited by this paper
• Recent advances in classical and non-classical antifolates as antitumor and antiopportunistic infection agents: part I.

  2007cited by this paper
• Receptor flexibility in de novo ligand design and docking.

  2005cited by this paper
• DNA and RNA synthesis: antifolates.

  2005cited by this paper
• Understanding the role of Leu22 variants in methotrexate resistance: comparison of wild-type and Leu22Arg variant mouse and human dihydrofolate reductase ternary crystal complexes with methotrexate and NADPH.

  2005cited by this paper
• Structure determination of tetrahydroquinazoline antifolates in complex with human and Pneumocystis carinii dihydrofolate reductase: correlations between enzyme selectivity and stereochemistry.

  2004cited by this paper
• Lessons in molecular recognition: the effects of ligand and protein flexibility on molecular docking accuracy.

  2004cited by this paper
• Deaza analogs of folic acid as antitumor agents.

  2003cited by this paper
• Anticancer antifolates: current status and future directions.

  2003cited by this paper
• Atomic structures of human dihydrofolate reductase complexed with NADPH and two lipophilic antifolates at 1.09 a and 1.05 a resolution.

  2002cited by this paper
• Pemetrexed disodium: a novel antifolate clinically active against multiple solid tumors.

  2001cited by this paper
• Trimetrexate as a biochemical modulator of 5-fluorouracil and leucovorin in colorectal cancer.

  2000cited by this paper
• Aliphatic α,γ‐bis(Amides) of Methotrexate. Influence of Chain Length on In‐vitro Activity Against Sensitive and Resistant Tumour Cells

  1999cited by this paper
• Comparison of two independent crystal structures of human dihydrofolate reductase ternary complexes reduced with nicotinamide adenine dinucleotide phosphate and the very tight-binding inhibitor PT523.

  1997cited by this paper
• Synthesis and antifolate activity of 2,4-diamino-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine analogues of trimetrexate and piritrexim

  1995cited by this paper
• Methotrexate-resistant Variants of Human Dihydrofolate Reductase with Substitutions of Leucine 22

  1995cited by this paper
• Methotrexate-resistant variants of human dihydrofolate reductase. Effects of Phe31 substitutions.

  1994cited by this paper
• The National Cancer Institute: cancer drug discovery and development program.

  1992cited by this paper
• Methotrexate pharmacokinetics following administration of recombinant carboxypeptidase-G2 in rhesus monkeys.

  1992cited by this paper
• Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines.

  1991cited by this paper
• The renewed potential for folate antagonists in contemporary cancer chemotherapy.

  1991cited by this paper

• Investigation of New Biologically Active Benzo[4,5]imidazo[1,2‐a]pyrimidine Derivatives as Broad‐Spectrum Antimicrobial Agents: Synthesis, Anti‐Biofilm, ROS and in Silico Studies

  2025cites this paper
• Symmetrical di-substituted phenylamino-s-triazine derivatives as anticancer agents: in vitro and in silico approach

  2025cites this paper
• 1,3,5-Triazine as a promising scaffold in the development of therapeutic agents against breast cancer.

  2024cites this paper
• Effects of solvent casted poly (lactic acid)/poly(ethylene glycol)/paraben derivative triazine films on antibacterial performance and cytotoxicity

  2024cites this paper
• DihydrofolateReductase (DHFR) Inhibitors: A Comprehensive Review.

  2023cites this paper
• Membrane-active substituted triazines as antibacterial agents against Staphylococcus aureus with potential for low drug resistance and broad activity.

  2023cites this paper
• New Benzimidazole-, 1,2,4-Triazole-, and 1,3,5-Triazine-Based Derivatives as Potential EGFRWT and EGFRT790M Inhibitors: Microwave-Assisted Synthesis, Anticancer Evaluation, and Molecular Docking Study

  2022cites this paper
• Human dihydrofolate reductase inhibition effect of 1-Phenylpyrazolo[3,4-d]pyrimidines: Synthesis, antitumor evaluation and molecular modeling study.

  2022cites this paper
• Condensation of 3,5-Dialkyltetrahydro-4H-thiopyran-4-ones with Formaldehyde

  2022cites this paper
• Dihydrofolate reductase inhibitors: patent landscape and phases of clinical development (2001–2021)

  2022cites this paper
• Recent Advances in the Biological Activity of s-Triazine Core Compounds

  2022cites this paper
• A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the Spotlight.

  2021cites this paper
• A microwave-assisted copper-mediated tandem approach for fused quinazoline derivatives.

  2021cites this paper
• Two Cu(II) and Zn(II) complexes derived from 5-(Pyrazol-1-yl)nicotinic acid: Crystal structure, DNA binding and anticancer studies

  2021cites this paper
• An Insight into Synthetic Strategies and Recent Developments of Dihydrofolate Reductase Inhibitors

  2021cites this paper
• Synthesis, biological evaluation, and in silico studies of novel chalcone- and pyrazoline-based 1,3,5-triazines as potential anticancer agents

  2020cites this paper
• DNA interaction analysis with automated biosensor of paraben derivative s-triazines

  2020cites this paper
• Synthesis, biological evaluation and molecular docking of pyrimidine and quinazoline derivatives of 1,5-benzodiazepine as potential anticancer agents

  2020cites this paper
• Fluorescent Supramolecular Assembly with Coronene Centers for Controlled DNA Condensation and Drug Delivery

  2019cites this paper
• Robust therapeutic potential of carbazole-triazine hybrids as a new class of urease inhibitors: A distinctive combination of nitrogen-containing heterocycles.

  2019cites this paper
• DHFR Inhibitors: Reading the Past for Discovering Novel Anticancer Agents

  2019cites this paper
• Recent Design and Structure-Activity Relationship Studies on Modifications of DHFR Inhibitors as Anticancer Agents.

  2019cites this paper
• Synthesis and molecular docking of pyrimidine incorporated novel analogue of 1,5-benzodiazepine as antibacterial agent

  2018cites this paper
• A structure‐based strategy toward the development of novel candidates for antimycobacterial activity: Synthesis, biological evaluation, and docking study

  2018cites this paper
• Novel 6-substituted benzoyl and non-benzoyl straight chain pyrrolo[2,3-d]pyrimidines as potential antitumor agents with multitargeted inhibition of TS, GARFTase and AICARFTase.

  2017cites this paper
• A new ferrocenyl-triazine Schiff base as a novel precursor for selective preparation of iron oxide nanostructures

  2017cites this paper
• Enantioselective Pd-Catalyzed Decarboxylative Allylic Alkylation of Thiopyranones. Access to Acyclic, Stereogenic α-Quaternary Ketones.

  2017cites this paper